










 













 




Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version














Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version














Versant Affiliates Fund V, L.P. - List of CEOs, founders and company directors

















directorpedia.net - List of CEOs, founders, board members and company directors











Versant Affiliates Fund V, L.P.
List of persons related to the company Versant Affiliates Fund V, L.P.. Find out list of CEOs, founders, board members, and company directors of Versant Affiliates Fund V, L.P..

CIK Number: 0001589095Company address: 3000 SAND HILL ROAD BUILDING 4, SUITE 210 MENLO PARK 94025Phone number: 650-233-7877



People related to Versant Affiliates Fund V, L.P.
NamePositionStreetCityCountryBolzon  Bradley3000 Sand Hill Road, Suite 4-210 Menlo ParkCANielsen  Kirk3000 Sand Hill Road, Suite 4-210 Menlo ParkCAL. Praeger  Robin3000 Sand Hill Road, Suite 4-210 Menlo ParkCAJaffe  Ross3000 Sand Hill Road, Suite 4-210 Menlo ParkCAJaffe  Ross3000 Sand Hill Road, Suite 4-210 Menlo ParkCAColella  Samuel3000 Sand Hill Road, Suite 4-210 Menlo ParkCAWoiwode  Tom3000 Sand Hill Road, Suite 4-210 Menlo ParkCAN/A  Versant Ventures V, LLC3000 Sand Hill Road, Suite 4-210 Menlo ParkCALink  William3000 Sand Hill Road, Suite 4-210 Menlo ParkCA




Versant Affiliates Fund V, L.P. on the Web
Related companiesVERSANT AFFILIATES FUND I-A LP, VERSANT AFFILIATES FUND I-B LP, VERSANT HOLDINGS INC, Versant Ophthalmic Affiliates I, L.P., VERSANT SIDE FUND I LP, Versant Side Fund II, LP, Versant Venture Capital V (Canada), LP, Versant Venture Capital V, L.P., Versant Venture Capital VI (Canada) LP, Versant Venture Capital VI, L.P., Versant Venture V AIV Feeder Holdings, L.P., Versant Venture V AIV, L.P.












 









Insider Trading - Versant Affiliates Fund V L.P. - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Versant Affiliates Fund V L.P.





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-10-24Purchase(A)
2016-12-236:03 pm
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
161,000
$14
$2,254,000
4,104,045(Indirect)
View




 (A) Indicate amendment filing.
 Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
437,247
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
3,100,477
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
231,077
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
2,754
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
19,524
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
1,454
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
2,210,417
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
173,167
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
66,490
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
5,210
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
168,224
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
13,180
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
73,704
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
5,774
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
437,247
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
2,754
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
3,100,477
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
19,524
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
2,210,417
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
66,490
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
168,224
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
73,704
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
231,077
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
1,454
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
173,167
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
5,210
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
13,180
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
5,774
$0
4,104,045(Indirect)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Fri, 28 Jul 2017 23:26:59 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  










Versant Affiliates Fund V, L.P. - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











Versant Affiliates Fund V, L.P.
Check out list of companies and businesses related to Versant Affiliates Fund V, L.P.. Find out Versant Affiliates Fund V, L.P. address and contact details. View other people related to Versant Affiliates Fund V, L.P. - coworkers, colleagues, companions, etc.
Address:   

ONE SANSOME STREET, SUITE 3630  SAN FRANCISCO 94104 CA




Companies related to Versant Affiliates Fund V, L.P.
CIKCompany NamePositionCompany Address0001674416CRISPR Therapeutics AGBAARERSTRASSE 14  ZUG CH-6300




Versant Affiliates Fund V, L.P. on the Web
Persons related to Versant Affiliates Fund V, L.P. - CRISPR Therapeutics AGNamePositionCityBehbahani  AliBaselAKTIENGESELLSCHAFT  BAYER51368 LEVERKUSENGlobal Investments B.V.  Bayer3641 RT MIJDRECHTMARC  BECKERAli  BehbahaniDirector TIMONIUMBradley J PhD  BolzonDirector MENLO PARKBolzon  BradleyBaselPABLO J  CAGNONIDirector DENVERCELGENE CORP /DE/10% Owner SUMMITN ANTHONY  COLESDirector CAMBRIDGETyler  Dylan-HydeChief Legal Officer CAMBRIDGEKURT VON  EMSTERDirector BOSTONSimeon  GeorgeDirector CONSHOHOCKENPLC  GLAXOSMITHKLINE10% Owner BRENTFORD MIDDLESEXHadley Harbor Master Investors (Cayman) L.P.10% Owner BOSTONSubramanian  KalaCambridgeJAMES R.  KASINGERCAMBRIDGESamarth  KulkarniPlease See Remarks CAMBRIDGEvon Emster  KurtBaselSven Ante  LundbergChief Scientific Officer CAMBRIDGEBecker  MarcCambridgeColes  N.BaselRodger  NovakChief Executive Officer CAMBRIDGECagnoni  PabloBaselNovak  RodgerBaselKulkarni  SamarthCambridgeGeorge  SimeonBaselKala  SubramanianSee Remarks CAMBRIDGELundberg  SvenCambridgeWoiwode  ThomasBaselDylan-Hyde  TylerCambridgeVersant Ophthalmic Affiliates I, L.P.SAN FRANCISCOVersant Side Fund IV, L.P.MENLO PARKVersant Venture Capital IV, L.P.10% Owner MENLO PARKVersant Venture Capital V (Canada), LPSAN FRANCISCOVersant Venture Capital V, L.P.SAN FRANCISCOThomas  WoiwodeDirector MENLO PARK












 









Insider Trading - Versant Ophthalmic Affiliates I L.P. - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Versant Ophthalmic Affiliates I L.P.





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-10-24Purchase(A)
2016-12-236:03 pm
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
161,000
$14
$2,254,000
4,104,045(Indirect)
View




 (A) Indicate amendment filing.
 Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
437,247
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
3,100,477
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
231,077
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
2,754
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
19,524
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
1,454
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
2,210,417
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
173,167
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
66,490
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
5,210
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
168,224
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
13,180
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
73,704
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
5,774
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
437,247
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
2,754
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
3,100,477
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
19,524
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
2,210,417
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
66,490
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
168,224
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
73,704
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
231,077
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
1,454
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
173,167
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
5,210
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
13,180
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
5,774
$0
4,104,045(Indirect)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Fri, 28 Jul 2017 23:26:59 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  













Home - Versant Ventures


































Search for:



 



Versant Ventures on LinkedIn

 

Share

LP Access
Contact Us
Careers














I've built two companies with Versant Ventures and value their distinctive investment approach. They have a clear understanding of the recipe for start-up company success and represent a premium brand in healthcare venture capital today.
David Clapper
 / Minerva Surgical
Versant. Invested in Life.





The people at Versant understand the entrepreneurial process. They take a long-term view of the portfolio company, and help provide perspective and support in times thick and thin.
Amar Sawhney
 / Ocular Therapeutix
Versant. Invested in Life.





Versant has been and continues to be a superb investor. They provide insight and counsel to our efforts and their willingness to roll up their sleeves to problem solve with us has been invaluable.
Michael D. Clayman, MD
 / Flexion Therapeutics
Versant. Invested in Life.











 


Featured Case Study




BIOTECHNOLOGY
Quanticel Pharmaceuticals
Quanticel technology is based on the work of Stanford researchers and company founders Stephen Quake and Michael Clarke. Versant had backed other genomic technologies invented by Quake, and moved quickly to incubate Quanticel in 2010, shortly after the company was founded.

The idea behind Quanticel’s single-cell genomic analysis technology is to unlock the mystery of cancer drug resistance through the analysis of tumor cell heterogeneity. As a tumor grows and cancer cells rapidly replicate, the genetic diversity of these cells increases...
Full Quanticel Pharmaceuticals Case Study








News Highlights

VenatoRx Pharmaceuticals Raises $42 Million Series B 
VenatoRxfinal 


Repare Therapeutics Raises $US68 Million Series A 
Repare Therapeutics Raises US$68 Million Series A 


CRISPR Therapeutics Announces the Appointment of Jon Terrett, Ph.D. to Head of Immuno-Oncology Research and Translation 
CRISPR appoints Jon Terrett 


Versant Ventures Launches Jecure Therapeutics 
jecure-series-a 























VERSANT VENTURE CAPITAL V, L.P. Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      VERSANT VENTURE CAPITAL V, L.P.
                    

•   SAN FRANCISCO, CA
                          • Venture Capital Fund
                      
How do I update this listing?




                                             Versant Venture Capital V is based out of San Francisco.    The firm last filed a Form D notice of exempt offering of securities on 2013-10-18. The filing was for a pooled investment fund:  venture capital fund The notice  included securities offered of Pooled Investment Fund Interests
                                           














Summary
13D/G
Insider (Form 4)
Form D 1



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from VERSANT VENTURE CAPITAL V, L.P., enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




versant venture capital v, l.p.


ONE SANSOME STREET

SAN FRANCISCO
CA
                                                        
                                                    94104


                                                      Business Phone:
                                                      650-233-7877







Recent SEC Filings




4/A filed on 12/23/2016
4 filed on 10/26/2016
3 filed on 10/18/2016
D/A filed on 06/30/2014
D filed on 10/18/2013
















Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...



Form D Filings

  Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission.
  Form D contains basic information about the offering and the company.


Form D Filings


Filing Date
Form Type
Industry Group
Securities Offered
Total Offering Amount
Total Amount Sold
Total Remaining




2013-10-18
D
POOLED INVESTMENT FUND:  VENTURE CAPITAL FUND

      Pooled Investment Fund Interests
    
250,000,000
0
250,000,000




Other Issuers in Filings


Name
Address




VERSANT AFFILIATES FUND V, L.P.

    3000 SAND HILL ROAD
    BUILDING 4, SUITE 210
    MENLO PARK, CA  94025
  


VERSANT OPHTHALMIC AFFILIATES I, L.P.

    3000 SAND HILL ROAD
    BUILDING 4, SUITE 210
    MENLO PARK, CA  94025
  




Related Parties included in filings


Name
Address
Relationship




BRADLEY   BOLZON

          subscription required
    


          DIRECTOR
      



CHARLES   WARDEN

          subscription required
    


          DIRECTOR
      



KIRK   NIELSEN

          subscription required
    


          DIRECTOR
      



N/A   VERSANT VENTURES V, LLC

          subscription required
    


          DIRECTOR
      



ROBIN L.  PRAEGER

          subscription required
    


          DIRECTOR
      



ROSS   JAFFE

          subscription required
    


          DIRECTOR
      



SAMUEL   COLELLA

          subscription required
    


          DIRECTOR
      



WILLIAM   LINK

          subscription required
    


          DIRECTOR
      











Elevate your investments
Try it for free

















